Health Care: Drugs

Acasti Pharma Inc (ACST: NASDAQ)

$0.3169 -0.0139 | -4.2%
07/06/15 - 04:00 PM ET
Company Cash Flow
Feb 2015 Feb 2014 Feb 2013 Feb 2012
Cash Flow From Operating Activities
Net Income (Loss) -1.32M -10.44M -6.73M -6.54M
Operating Gains/Losses 1.28K 0.00 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 236.49K -282.47K 241.06K -640.35K
(Increase) Decrease in Inventories 139.18K -35.33K 368.58K -602.93K
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 361.07K -78.23K 1.16M 186.66K
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital 0.00 0.00 0.00 0.00
Other Non-Cash Items -7.35M 3.74M 1.80M 1.30M
Net Cash From Continuing Operations -5.76M -6.12M -2.49M -5.65M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -5.76M -6.12M -2.49M -5.65M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 17.71M 5.39M 1.95M 4.53M
Purchases of Property, Plant & Equipment -68.70K -133.56K -100.68K 0.00
Acquisitions 0.00 0.00 0.00 0.00
Purchases of Short-Term Investments -11.58M -22.82M 0.00 -7.54M
Other Cash from Investing Activities 32.78K 88.20K 1.74K 8.17K
Cash Provided by Financing Activities
Net Cash From Investing Activities 6.10M -17.48M 1.85M -3.01M
Issuance of Debt 0.00 0.00 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 39.98K 873.74K 224.15K 9.95M
Repayment of Long-Term Debt 0.00 0.00 0.00 0.00
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -3.25K 21.56M -2.62K -9.01K
Net Cash From Financing Activities 36.73K 22.44M 221.53K 9.94M
Effect of Exchange Rate Changes 127.97K 689.10K 29.45K -9.54K
Net Change in Cash & Cash Equivalents 507.82K -468.32K -384.12K 1.27M
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter